Press releases

Scholar Rock Announces Proposed Public Offering of Common Stock

Read This Press Release

Scholar Rock Announces Positive Proof-of-Concept Data from TOPAZ Phase 2 Trial Interim Analysis of SRK-015 in Patients with Type 2 and Type 3 Spinal Muscular Atrophy

Read This Press Release

Scholar Rock Secures $50 million Debt Facility with Silicon Valley Bank and Oxford Finance

Read This Press Release

Scholar Rock Presents Data for SRK-015 at the World Muscle Society 2020 Virtual Congress

Read This Press Release

Scholar Rock Announces First Patient Dosed in Part A2 of DRAGON Phase 1 Proof-of-Concept Trial of SRK-181 to Overcome Primary Resistance to Anti-PD-(L)1 Therapy

Read This Press Release

Scholar Rock to Present at Upcoming Healthcare Conferences

Read This Press Release

Scholar Rock Announces Issuance of U.S. Patent Providing Composition of Matter Protection for SRK-015

Read This Press Release

Scholar Rock Announces that SRK-015 has Received Rare Pediatric Disease Designation from U.S. FDA for the Treatment of Spinal Muscular Atrophy

Read This Press Release